BioSpace News Archive

Policy

Statement from the Chief Public Health Officer of Canada on August 16, 2020

In lieu of an in-person update to the media, Dr. Theresa Tam, Canada’s Chief Public Health Officer, issued the following statement

August 16, 2020
·
2 min read
Deals

Ascentage Pharma Becomes a Constituent of Three Major Indexes Including Hang Seng Composite Index

Ascentage Pharma announced that the company has been selected as a constituent stock of the Hang Seng Composite Index, the Hang Seng Hong Kong-Listed Biotech Index and the Hang Seng Healthcare Index in accordance with the quarterly adjustment results of the latest index series released by Hang Seng Indexes Company Limited, with effect from September 7th, 2020.

August 16, 2020
·
4 min read
Drug Development

First HBV Patient Dosed in Phase IIa Clinical Trial of ASC22, a Subcutaneously Administered PD-L1 Antibody

Ascletis Pharma Inc. announces dosing of the first HBV patient in Phase IIa clinical trial of ASC22, which is a first-in-class, subcutaneously administered PD-L1 antibody.

August 16, 2020
·
4 min read